Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors

BackgroundHuman papillomavirus positive (HPV+) head and neck squamous cell carcinoma (HNSCC) is an emerging disease, representing a distinct clinical and epidemiological entity. Understanding the genetic basis of this specific subtype of cancer could allow therapeutic targeting of affected pathways for a stratified medicine approach.MethodsTwenty HPV+ and 20 HPV- laser-capture microdissected oropharyngeal carcinomas were used for paired-end sequencing of hybrid-captured DNA, targeting 3,230 exons in 182 genes often mutated in cancer. Copy number alteration (CNA) profiling, Sequenom MassArray sequencing and immunohistochemistry were used to further validate findings.ResultsHPV+ and HPV- oropharyngeal carcinomas cluster into two distinct subgroups. TP53 mutations are detected in 100% of HPV negative cases and abrogation of the G1/S checkpoint by CDKN2A/B deletion and/or CCND1 amplification occurs in the majority of HPV- tumors.ConclusionThese findings strongly support a causal role for HPV, acting via p53 and RB pathway inhibition, in the pathogenesis of a subset of oropharyngeal cancers and suggest that studies of CDK inhibitors in HPV- disease may be warranted. Mutation and copy number alteration of PI3 kinase (PI3K) pathway components appears particularly prevalent in HPV+ tumors and assessment of these alterations may aid in the interpretation of current clinical trials of PI3K, AKT, and mTOR inhibitors in HNSCC.

• Publication year

  2013

• Venue

  Genome Medicine

• Publication date

  2013-05-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/gm453PMID 23718828PMCID 4064312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human papillomavirus and head and neck cancer.

  2015cited by this paper
• Using high-density DNA methylation arrays to profile copy number alterations

  2014cited by this paper
• Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma

  2013cited by this paper
• Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

  2012cited by this paper
• mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas

  2012influential reference
• Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma.

  2012cited by this paper
• mTOR Inhibitors and its Role in the Treatment of Head and Neck Squamous Cell Carcinoma

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• Absolute quantification of somatic DNA alterations in human cancer

  2012cited by this paper
• Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development.

  2012cited by this paper
• An integrated view of cyclin E function and regulation

  2012cited by this paper
• The molecular biology of head and neck cancer

  2011cited by this paper
• Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma

  2011cited by this paper
• TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico

  2011cited by this paper
• The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

  2011cited by this paper
• Clinical Assessment of PTEN Loss in Endometrial Carcinoma: Immunohistochemistry Out-Performs Gene Sequencing

  2011cited by this paper
• PI3K‐dependent phosphorylation of Fbw7 modulates substrate degradation and activity

  2011cited by this paper
• Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination

  2011cited by this paper
• A framework for variation discovery and genotyping using next-generation DNA sequencing data

  2011cited by this paper
• Localization‐specific LKB1 loss in head and neck squamous cell carcinoma metastasis

  2011cited by this paper
• Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1

  2011cited by this paper
• Why are de Bruijn graphs useful for genome assembly?

  2011cited by this paper
• Allele-specific copy number analysis of tumors

  2010cited by this paper
• A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data

  2010cited by this paper
• Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer.

  2010cited by this paper
• The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of function

  2010cited by this paper
• COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

  2010cited by this paper
• Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma

  2010cited by this paper
• SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.

  2010cited by this paper
• A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes

  2010cited by this paper
• Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis

  2010cited by this paper
• Human Papillomavirus and Oropharyngeal Cancer: What You Need to Know in 2009

  2009cited by this paper
• The Sequence Alignment/Map format and SAMtools

  2009cited by this paper
• Human Papillomavirus and Head and Neck Cancer

  2009cited by this paper
• Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

  2008cited by this paper
• Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas.

  2007influential reference
• Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

  2007cited by this paper
• A faster circular binary segmentation algorithm for the analysis of array CGH data

  2007cited by this paper
• Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

  2006cited by this paper
• Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.

  2004cited by this paper
• Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex.

  2004cited by this paper
• The LKB1 tumor suppressor negatively regulates mTOR signaling.

  2004cited by this paper
• Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.

  2004cited by this paper
• A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.

  2001influential reference
• Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease

  2001cited by this paper
• Molecular biology of head and neck cancer.

  1994cited by this paper
• BASIC SCIENCE REVIEW

  year unknowncited by this paper
• BIOINFORMATICS ORIGINAL PAPER

  year unknowncited by this paper

• Coupling CZE, Liquid-Phase Ion Mobility, to MS/MS for Quantitative Top-Down Proteomics: Revealing Significant Proteoform Differences Between Healthy and Alzheimer's Disease Brains.

  2025cites this paper
• VOYAGER: an international consortium investigating the role of human papilloma virus and genetics in oral and oropharyngeal cancer risk and survival

  2025cites this paper
• Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis

  2025influential citation
• HPV status shapes T-cell immunoprofiles in oesophageal adenocarcinoma: high regulatory T cell infiltration predicts poor prognosis

  2025cites this paper
• Nrf2 hyperactivation as a driver of radiotherapy resistance and suppressed anti-tumor immunity in head and neck squamous cell carcinoma.

  2025cites this paper
• Cancer Stem Cell Mechanisms and Targeted Therapeutic Strategies in Head and Neck Squamous Cell Carcinoma.

  2025cites this paper
• Screening for oropharyngeal cancer: the time is now

  2025cites this paper
• Circulating cell free HPVDNA in HPV positive head and neck cancer reveals fast responders and early peakers during treatment

  2025cites this paper
• Therapeutic options for human papillomavirus‐positive tonsil and base of tongue cancer

  2025cites this paper
• Molecular mechanisms of human papillomavirus-induced tongue carcinogenesis: A systematic review

  2025cites this paper
• Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell Lines

  2025cites this paper
• Cancer Chemotherapy: Combination with Inhibitors (Volume I)

  2024cites this paper
• SP1 Gene Methylation in Head and Neck Squamous Cell Cancer in HPV-Negative Patients

  2024cites this paper
• The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling

  2024cites this paper
• Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.

  2024cites this paper
• Massive parallel sequencing of head and neck conventional squamous cell carcinomas: A comprehensive review

  2024cites this paper
• LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma

  2024cites this paper
• Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status

  2024cites this paper
• Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer

  2023cites this paper
• Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection

  2023cites this paper
• Causal Link of Human Papillomavirus in Barrett Esophagus and Adenocarcinoma: Are We There Yet?

  2023cites this paper
• Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary.

  2023cites this paper
• Gene Expression Profiles of Methyltransferases and Demethylases Associated with Metastasis, Tumor Invasion, CpG73 Methylation, and HPV Status in Head and Neck Squamous Cell Carcinoma

  2023cites this paper
• Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma

  2023cites this paper
• Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma

  2023influential citation
• PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications

  2023cites this paper
• Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma

  2022cites this paper
• Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors

  2022cites this paper
• HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management

  2022cites this paper
• Sustained Expression of HPV16 E7 Oncoprotein Promotes p-AKT (Ser473)/p-Src (Tyr527) Signalling to Drive Precancerous Lesions to Invasive Cervical Cancer.

  2022cites this paper
• Characterization of epigenomic alterations in HPV16+ head and neck squamous cell carcinomas.

  2022cites this paper
• Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited

  2022cites this paper
• Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas

  2022cites this paper
• Prognostic role of p16 overexpression in sinonasal squamous cell carcinoma: A retrospective analysis of Alberta patients

  2022cites this paper
• Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression

  2021cites this paper
• Non-Thermal Reactive N2/He Plasma Exposure to Inhibit Epithelial Head and Neck Tumor Cells

  2021cites this paper
• Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis

  2021cites this paper
• Targeted Next-Generation Sequencing of Cancer-Related Genes in a Norwegian Patient Cohort With Head and Neck Squamous Cell Carcinoma Reveals Novel Actionable Mutations and Correlations With Pathological Parameters

  2021influential citation
• Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Prognostic value and cost benefit of HPV testing for oropharyngeal cancer patients.

  2021cites this paper
• What's New in Molecular Targeted Therapies for Head and Neck Cancer?

  2021cites this paper
• Genomic Signature of Oral Squamous Cell Carcinomas from Non-Smoking Non-Drinking Patients

  2021cites this paper
• Prevalence of High-Risk Nonvaccine Human Papillomavirus Types in Advanced Squamous Cell Carcinoma Among Individuals of African vs Non-African Ancestry.

  2021cites this paper
• Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma

  2021cites this paper
• Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations

  2021cites this paper
• Insights of Cisplatin Resistance in Cervical Cancer: A Decision Making for Cellular Survival

  2021cites this paper
• Metabolomics of Oral/Head and Neck Cancer.

  2021cites this paper
• Signatures of copy number alterations in human cancer

  2021cites this paper
• DNA Methylation and HPV-Associated Head and Neck Cancer

  2021cites this paper
• Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status

  2021cites this paper
• Whole-Exome Sequencing of HPV Positive Tonsillar and Base of Tongue Squamous Cell Carcinomas Reveals a Global Mutational Pattern along with Relapse-Specific Somatic Variants

  2021cites this paper
• The Role of Human Papilloma Virus in Dictating Outcomes in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• mTOR pathway and DNA damage response: A therapeutic strategy in cancer therapy.

  2021cites this paper
• Worldwide Prevalence of PI3K-AKT-mTOR Pathway Mutations in Head and Neck Cancer: A Systematic Review and Meta-Analysis.

  2021cites this paper
• Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues

  2021cites this paper
• Pathology of HPV-Associated Head and Neck Carcinomas: Recent Data and Perspectives for the Development of Specific Tumor Markers

  2020cites this paper
• Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial

  2020cites this paper
• The role of Hippo‐YAP signaling in squamous cell carcinomas

  2020influential citation
• Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns

  2020cites this paper
• Metabolic regulation in HPV associated head and neck squamous cell carcinoma.

  2020cites this paper
• Disparities in Head and Neck Cancer: A Case for Chemoprevention with Vitamin D

  2020cites this paper
• Unraveling most abundant mutational signatures in head and neck cancer

  2020cites this paper
• Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms

  2020cites this paper
• Title- Genomic landscape of squamous cell carcinoma- Different genetic pathways culminating in a common phenotype.

  2020cites this paper
• Stratification of HPV‐associated and HPV‐negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes

  2020cites this paper
• Differential mutation spectrum and immune landscape in African Americans versus whites: A possible determinant to health disparity in head and neck cancer.

  2020cites this paper
• Molecular Diagnostics in Head and Neck Squamous Cell Carcinoma

  2019cites this paper
• Molecular genetics of head and neck squamous cell carcinoma

  2019cites this paper
• APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma

  2019cites this paper
• PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer.

  2019cites this paper
• Unraveling cancer lineage drivers in squamous cell carcinomas.

  2019cites this paper
• mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy

  2019cites this paper
• A global epidemic increase of an HPV‐induced tonsil and tongue base cancer – potential benefit from a pan‐gender use of HPV vaccine

  2019cites this paper
• A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy.

  2019cites this paper
• Beyond EGFR Targeting in SCCHN: Angiogenesis, PI3K, and Other Molecular Targets

  2019cites this paper
• Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation

  2019cites this paper
• Discovery of a novel tumor suppressor from the autophagy regulatory network: LRRK2 in lung adenocarcinoma

  2019cites this paper
• Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models

  2019cites this paper
• Genetic alterations in human papillomavirus-associated oropharyngeal squamous cell carcinoma of patients with treatment failure.

  2019cites this paper
• Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness

  2019cites this paper
• Targeted Next-Generation Sequencing in Head and Neck Cancer

  2018cites this paper
• Molecular Regulation of Cell Cycle and Cell Cycle-Targeted Therapies in Head and Neck Squamous Cell Carcinoma (HNSCC)

  2018cites this paper
• Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma

  2018cites this paper
• Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations

  2018cites this paper
• Das HPV-getriebene Oropharynxkarzinom – Inzidenz, Trends, Diagnose und Therapie

  2018cites this paper
• Detection of High-Risk Human Papillomavirus in Oral Cavity Squamous Cell Carcinoma Using Multiple Analytes and Their Role in Patient Survival

  2018cites this paper
• A Review of HPV-Related Head and Neck Cancer

  2018cites this paper
• Predicting cancer outcome: Artificial intelligence vs. pathologists.

  2018cites this paper
• HPV – A different view on Head and Neck Cancer

  2018cites this paper
• Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature

  2018cites this paper
• Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.

  2018cites this paper
• Deciphering the cells of origin of squamous cell carcinomas

  2018cites this paper
• Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma

  2018cites this paper
• Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer

  2018cites this paper
• Targeting epithelial-to-mesenchymal transition (EMT) in feline oral squamous cell carcinoma (FOSCC)

  2018cites this paper
• Therapeutic Implications of the Genetic Landscape of Head and Neck Cancer.

  2018cites this paper
• HPV-Associated Oropharyngeal Cancer in the HIV/AIDS Patient.

  2018cites this paper
• Mutational burden and prognostic factors in a cohort of homogenously treated Spanish HNSCC patients

  2018cites this paper
• Improving Therapeutics In Head And Neck Cancer

  2018cites this paper
• [Genomic characterization of head and neck squamous cell carcinoma: Impact and challenges for therapeutic management].

  2018cites this paper